Field Application Scientist, Sengenics
Biography
Joseph Miseirvitch is a scientist with a passion for solving the unknowns in cellular, molecular, and biological pathways with over 10 years of experience in the life sciences. He is currently the Field Application Scientist for Sengenics covering North America.
Clinical & Research Tools Showcase:
Sengenics
Sengenics is a precision medicine company founded in the desire to improve patient outcomes based on physiologically relevant, data-guided, decision making. Our platform enables the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction and development of companion diagnostics.
Autoantibody Biomarkers - Response Prediction in Immuno-Oncology
The understanding of the immune response to cancer can be harnessed to better comprehend outcomes and response to therapeutics. Sengenics platform enables discovery and validation of highly predictive autoantibody biomarker signatures for guiding treatment decision making.
Session Abstract – PMWC 2022 Silicon Valley
Track 6 - June 28 4.00 P.M.-4.15 P.M.,Track 6 - June 29 9.00 A.M.-1.15 P.M.,Track 6 - June 30 1.45 P.M.-2.00 P.M.
The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
